ReviewInfection and drug resistance2025
Extrapulmonary Comparisons Between
Review in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Clinical utility of targeted next-generation sequencing for rapid detection, species differentiation, drug resistance profiling, and prognostic evaluation inFrontiers in cellular and infection microbiology · 2026Article
- Temporal trends, diagnostics, and outcomes of pediatric nontuberculous mycobacterial disease in Slovakia (2017-2024).Frontiers in public health · 2026Article
- Computational and Experimental Characterization ofBioinformatics and biology insights · 2026Article
- Integrative Medicine Treatment Strategy for Tuberculosis of the Breast Combined with Granulomatous Mastitis: A Case Report.International journal of women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of tuberculosis (TB) and non-tuberculous mycobacteria (NTM) diseases and the number of deaths from these diseases are steadily increasing worldwide. However, the pathologic diagnosis of NTM disease is similar to that of tuberculosis, and it is often difficult to distinguish between the two, which can lead to misdiagnosis and treatment aversion. Therefore, differentiation between the two can help in accurate diagnosis and treatment planning. This review compares the presentation, diagnosis, and treatment of common extrapulmonary sites of involvement in tuberculosis and non-tuberculous mycobacterial disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.